摘要:
A number of 5-substituted 3-hydroxymethylpyrimido[1,6-c][1,3]oxazine derivatives were synthesized and evaluated for their biological activity. Compound (10) showed slight activity (GI(50) = 2.7 mu M) against MDA-MB-231/ATTC Breast Cancer cell line.